Literature DB >> 33026168

Outcome of 45,X fetuses with cystic hygroma: A systematic review.

Ariel T Levy1, Vincenzo Berghella1, Huda B Al-Kouatly1.   

Abstract

This objective of this systematic review was to estimate live birth rate and explore prognostic indicators in fetuses with 45,X karyotype and a posterior cystic hygroma (CH). Electronic databases were searched and studies reporting pregnancy outcomes (termination, spontaneous abortion, demise, or live birth) for fetuses with 45,X karyotype and a CH diagnosed on ultrasound were included. For cases of survival, CH characteristics, presence of hydrops fetalis, or concomitant anomalies, delivery details, and postnatal outcomes were summarized. A total of 95 studies, including 535 cases, met inclusion criteria: 285 (53.3%) pregnancies were terminated, 72 (13.5%) had spontaneous abortion or demise, 164 (30.7%) had unspecified pregnancy failure, and 14 (2.6%) were live births. Among live births with data available, all CH measured 2-7 cm, more than half were septate, and almost all regressed in size or eventually disappeared. Hydrops fetalis was noted in five cases. Of the eight live births with neonatal outcomes available, three neonates died shortly after birth and five survived past the neonatal period. This review suggests that diagnosis of CH in a 45,X fetus is associated with an estimated live birth rate of 2.6%, but only 1% survive to infancy. Prognosis appears to improve with CH regression.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Monosomy X; cystic hygroma; live birth; prognosis; survival

Mesh:

Year:  2020        PMID: 33026168     DOI: 10.1002/ajmg.a.61902

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Phenotypic and Genomic Analysis of Cystic Hygroma in Pigs.

Authors:  Anna Letko; Alexandria Marie Schauer; Martijn F L Derks; Llorenç Grau-Roma; Cord Drögemüller; Alexander Grahofer
Journal:  Genes (Basel)       Date:  2021-01-31       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.